Share.

    3 Kommentare

    1. „The researchers developed a novel tool using an approach called chemogenetics, which allows specific cell functions to be controlled by synthetic compounds. In chemogenetics, receptors are genetically engineered so they no longer respond to the body’s natural molecules but can instead be activated by an otherwise inert chemical. In this case, the team created a receptor called mitoDREADD-Gs. DREADD stands for “Designer Receptor Exclusively Activated by Designer Drug,” and these receptors are designed to respond only to a lab-made compound called clozapine-N-oxide.“

    2. A portion of my thesis work looked at mitochondria transport in neurodegenerative disease. Transport is impaired. I’m not sure about activity but it’s always good to look at causes other than „plaque formation and accumulation“ which has plagued the field for decades

    Leave A Reply